Option chain shows key data for Nanalysis Scientific's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Nanalysis Scientific.

Nanalysis Scientific (OTC:NSCIF) Stock, Option Chain

Nanalysis Scientific Corp designs, manufactures and sells a range of nuclear magnetic resonance (NMR) technologies that go into a range of NMR spectrometers and magnetic resonance imaging (MRI) equipment. The company's original product, the 60 MHz MR spectrometer, was the first full-featured benchtop NMR spectrometer available on the market. The Company's activities are carried out through three operating segments, within which are two reportable segments which include Scientific Equipment which includes sales of proprietary and third-party products and Security Services involves maintenance and installation of security equipment. Geographic segments of the group are the U.S., Europe, Canada, Asia, and Other regions.

Penny Stocks

Small Cap

Markets

ADVZF

ARREF

ASMIY

BDRAF

BDRBF

CCNB

CNIG

CNIGO

CNIGP

CNSNF

CRSXF

CTSDF

DYLLF

ELRRF

ENZN

ETCG

ETHE

FCUUF

FFNTF

FLMMF

GBTC

GDLC

GDNSF

GLOBAL ATOMIC CORP by Global Atomic Corp.

GLATF

GRRB

HEOFF

IPOOF

ISENF

IVPAF

JRNGF

MLNLF

MRMD

MRVFF

NDVAF

NIOBF

NKOSF

NNXPF

NSCIF

NTTHF

NVNXF

OBELF

OPSSF

OTCM

POETF

PTRUF

SVBT

TAALF

TBTC

THBRF

TRBMF

UNRIVALED BRANDS INC by Unrivaled Brands, Inc.

UNRV

WOWMF

WSTRF

YZCAY

YZCHF

Photo by Yiorgos Ntrahas on Unsplash

This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.

The 2022 OTCQX Best 50 Has Been Announced — Here Are The Companies That Made The Cut

NANALYSIS SCIENTIFIC CORP by Nanalysis Scientific Corp.

Nanalysis Scientific Corp

Press Releases

Nanalysis Announces New Director and Results of AGM

Nanalysis Announces Second Quarter 2024 Conference Call

Earnings

Nanalysis Announces Second Quarter 2024 Results

Nanalysis to Present at the LD Micro Main Event XVII

Nanalysis Announces Third Quarter 2024 Conference Call

Nanalysis Announces Third Quarter 2024 Results

Nanalysis and The United States Pharmacopeia (USP) Co-Publish Study Demonstrating Efficacy of Benchtop NMR for Quality Control

Nanalysis Provides Fourth Quarter Preview (Unaudited)

TSXV:NSCI

Nanalysis Scientific

Comments

Nanalysis Scientific

Nanalysis Scientific (NSCIF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga